Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, a doctor can prescribe tirzepatide — but whether yours will depends entirely on which route you take and whether you meet the criteria. In the UK, tirzepatide (sold as Mounjaro) is a prescription-only medicine, so a qualified prescriber must assess your suitability before any treatment begins. That prescriber could be your GP, a specialist, or a GPhC-registered Independent Prescriber working through a regulated private service. The route shapes the timeline, the eligibility bar, and what support you receive alongside it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misunderstanding is that tirzepatide works like a cholesterol tablet, something a GP can dash off on a repeat. That's not quite how it works, and understanding why saves a lot of frustration.
For the NHS route, NICE recommended tirzepatide in December 2024 (TA1026), but with a phased rollout tied to strict eligibility thresholds. As of mid-2026, the first NHS cohort requires a BMI of 40 or above plus four or more qualifying conditions from a defined list: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. A second cohort (BMI 35–39.9 with four or more of those conditions) opened in June 2026. Broader access follows in stages through 2027. So your GP might genuinely want to prescribe and still be unable to under current NHS rules.
From April 2026, GP practices can prescribe tirzepatide under the new QOF contract, but participation is optional, so whether your surgery is doing this varies by practice and region. Even where it is available, every NHS patient must engage with a wraparound diet and activity support programme. Meeting the criteria on paper doesn't guarantee a prescription. You can read the full NICE eligibility recommendations in NICE technology appraisal TA1026.
If you don't meet the NHS thresholds, or your surgery isn't yet participating, your GP's options are limited. They can refer you to a specialist weight management service, which may have its own waiting list. They can discuss lifestyle support. But prescribing tirzepatide outside the NHS framework isn't something most GPs will do through the standard NHS consultation.
A private prescription is the other legal route. Under tirzepatide's UK licence, adults with a BMI of 30 or above (or 27 and above alongside a weight-related condition) are eligible for clinical assessment. The prescription doesn't have to come from your own GP. A GPhC-registered Independent Prescriber working through a regulated private pharmacy can carry out the full assessment and, if you're clinically suitable, issue a prescription. That's the route Mounjaro through nume follows: a prescriber reads your consultation the same day, not software making an automated call.
It's worth knowing that the private licensed eligibility criteria are broader than the current NHS thresholds. If your BMI is 32 and you have hypertension, you almost certainly won't qualify under today's NHS rules, but you may well be suitable through a private clinical assessment. Details on how that assessment works are covered on our Mounjaro prescription page.
Whether NHS or private, a prescriber doesn't rubber-stamp a request. They weigh up your full picture: BMI, weight-related conditions, medical history, current medicines, and any contraindications. Tirzepatide isn't suitable for everyone, and the prescriber is the person who makes that call.
A few practical things come up repeatedly at assessment. Oral contraceptive users starting tirzepatide need to add a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because the medicine can affect pill absorption. Anyone on HRT may want to discuss transdermal options with their doctor. And if you're having surgery, your anaesthetist needs to know. These aren't scare stories, they're the kind of details a real clinical review surfaces, which is exactly why a prescriber, not an algorithm, has to be involved. The NHS tirzepatide medicines page covers the main clinical considerations.
For a fuller picture of the eligibility criteria and what affects your BMI threshold, the Mounjaro BMI eligibility guide walks through how those numbers work in practice. If you have specific questions about timing, for example whether it's clinically fine to take tirzepatide a day early if an injection day falls at an inconvenient time, our tirzepatide suitability guide covers questions like that. For anything more specific about scheduling, the prescriber is always the right person to ask directly.
Ordering before noon on a weekday (say, a Wednesday morning before the school run) means your consultation can be reviewed, approved if suitable, and dispatched the same day. The pen arrives with DPD the next working day, tracked, in plain packaging. That's the timeline for the private route through nume when everything lines up clinically.
But the timeline isn't the point. The point is whether it's safe and legitimate. The question to ask of any online pharmacy is whether you can verify it. Every regulated UK pharmacy has a GPhC premises number listed on the GPhC register, and you can look it up. nume's number is 9012878. A consultation that includes photo-ID verification, live weight confirmation on video, and a clinician reviewing your Summary Care Record where relevant is substantively different from a tick-box form. It's also substantively different from sellers offering these medicines without a valid prescription, which the MHRA has repeatedly warned is a route to counterfeit product. Those warnings are taken seriously here.
If you want to understand the full cost picture before deciding, our guide to buying Mounjaro online covers what private treatment typically costs and what a legitimate price should include. Treatment options across our service are also summarised on the weight loss treatments overview.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.